Treatment

Maplirpacept clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase I and Phase II (Integrated)- Other
C4971006: A PHASE 1b/2, OPEN-LABEL STUDY OF PF-07901801 IN COMBINATION WITH GLOFITAMAB AFTER A FIXED, SINGLE DOSE OF OBINUTUZUMAB IN PARTICIPANTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA NOT ELIGIBLE FOR STEM CELL TRANSPLANTATION
This study looks at a new combination of medicines for adults with a type of blood cancer called Diffuse Large B Cell Lymphoma that has come back or is hard to treat. It checks how safe the medicines are and how well they work.
For: Relapsed/Refractory Diffuse Large B Cell Lymphoma
Spain · France · Germany